Dragon1988
commented on
$NeuroBo Pharmaceuticals (NRBO.US)$ such bull shit... lol
2
Dragon1988
commented on
$KALEIDO BIOSCIENCES INC (KLDO.US)$ on moomoo this shows delisted and webull its been pulled and nontradeable. becareful with this one
7
Dragon1988
commented on
$KALEIDO BIOSCIENCES INC (KLDO.US)$ Is this stock going to be delisted?
Translated
1
Dragon1988
liked
Dragon1988
voted
Life's a struggle. Anyhow, life still goes on
Tasted all the flavors of life, and what came after them are countless troubles
How many problems do you need to face every day
How many nights, agony is the thing keeping you awake
— Shawn Sung
Some people may have the same feeling because that's how life works. So close your eyes, and everything will be alright.
Maybe things will get wors...
Tasted all the flavors of life, and what came after them are countless troubles
How many problems do you need to face every day
How many nights, agony is the thing keeping you awake
— Shawn Sung
Some people may have the same feeling because that's how life works. So close your eyes, and everything will be alright.
Maybe things will get wors...
+10
97
80
Dragon1988
liked
$Johnson & Johnson (JNJ.US)$ $SINOPHARM (01099.HK)$ COVID-19 vaccines from U.S. drugmaker Johnson & Johnson and China's Sinopharm as well as Russia's Sputnik V shot had no neutralizing activity against the Omicron variant, according to a study which has not yet been peer reviewed.
The Omicron variant has raised concerns regarding its ability to evade protection provided by widely-used vaccines, with drugmakers tailoring their shots to target the variant while testing the effectiveness of their existing shots.
Vaccines from $Moderna (MRNA.US)$ , $ASTRAZENECA PLC (AZNCF.US)$ and $Pfizer (PFE.US)$ and partner $BioNTech (BNTX.US)$ retained activity against Omicron, but the antibody response was greatly reduced when compared with the original virus strain first detected in China, the study found.
The study also found that while the effectiveness of $GlaxoSmithKline (GSK.US)$ and Vir Biotech's COVID-19 drug sotrovimab reduced three-fold against Omicron compared to the original strain, monoclonal antibody treatments by Regeneron and Eli Lilly completely lost their neutralizing activity against the variant.
The finding is consistent with recent laboratory tests demonstrating the two treatments lose most of their effectiveness when exposed to the Omicron variant.
The Omicron variant has raised concerns regarding its ability to evade protection provided by widely-used vaccines, with drugmakers tailoring their shots to target the variant while testing the effectiveness of their existing shots.
Vaccines from $Moderna (MRNA.US)$ , $ASTRAZENECA PLC (AZNCF.US)$ and $Pfizer (PFE.US)$ and partner $BioNTech (BNTX.US)$ retained activity against Omicron, but the antibody response was greatly reduced when compared with the original virus strain first detected in China, the study found.
The study also found that while the effectiveness of $GlaxoSmithKline (GSK.US)$ and Vir Biotech's COVID-19 drug sotrovimab reduced three-fold against Omicron compared to the original strain, monoclonal antibody treatments by Regeneron and Eli Lilly completely lost their neutralizing activity against the variant.
The finding is consistent with recent laboratory tests demonstrating the two treatments lose most of their effectiveness when exposed to the Omicron variant.
33
4
Dragon1988
liked
$Qraft AI-Enhanced U.S. Large Cap Momentum ETF (AMOM.US)$ an exchange-traded fund driven by artificial intelligence, has acquired new stakes in $Tesla (TSLA.US)$ , $Netflix (NFLX.US)$ and $Autodesk (ADSK.US)$ , while entirely divesting its holdings in $Intel (INTC.US)$ , $PayPal (PYPL.US)$ and $Moderna (MRNA.US)$ .
What Happened: The ETF’s latest portfolio after rebalancing in early December showed that it has also entirely divested its holdings in technology company $IBM Corp (IBM.US)$ and oil giant $ConocoPhillips (COP.US)$ .
The ETF, which has assets under management of $27.07 million, has a history of accurately predicting the price movements of Tesla’s shares.
The fund now has electric vehicle maker Tesla as its largest investment with a 7.7% weighting, followed by streaming giant Netflix with a weighting of 6.8% and biotechnology firm $Merck & Co (MRK.US)$ with 5.1% weighting.
The other two stocks that make up the top five holdings in the AMOM portfolio are software company Autodesk with a 2.5% weighting and glucose monitoring systems maker $DexCom (DXCM.US)$ with 2.4%.
Prior to the rebalancing, the ETF had Intel, PayPal, Moderna, IBM and ConocoPhillips as its five largest holdings.
What Happened: The ETF’s latest portfolio after rebalancing in early December showed that it has also entirely divested its holdings in technology company $IBM Corp (IBM.US)$ and oil giant $ConocoPhillips (COP.US)$ .
The ETF, which has assets under management of $27.07 million, has a history of accurately predicting the price movements of Tesla’s shares.
The fund now has electric vehicle maker Tesla as its largest investment with a 7.7% weighting, followed by streaming giant Netflix with a weighting of 6.8% and biotechnology firm $Merck & Co (MRK.US)$ with 5.1% weighting.
The other two stocks that make up the top five holdings in the AMOM portfolio are software company Autodesk with a 2.5% weighting and glucose monitoring systems maker $DexCom (DXCM.US)$ with 2.4%.
Prior to the rebalancing, the ETF had Intel, PayPal, Moderna, IBM and ConocoPhillips as its five largest holdings.
16
Dragon1988
liked
3
1
Dragon1988
liked
1
Dragon1988 : Trap